RedHawk Pharma LLC is in negotiations to purchase undisclosed cannabis assets in Oklahoma.
The news was announced Friday by parent company RedHawk Holdings Corp. SNDD, a diversified holding company focused on sales and distribution of medical devices.
According to the press release, specific cannabis assets include licenses to grow, manufacture, and sell within the state.
The company stressed that the focus is on "craft" cultivation as well as the distribution of product.
The potential deal closing would take place before the year-end.
It is subject to the approval of RedHawk's board of directors as well as acceptance and approval by the seller's board of directors and shareholders, among others.
The Lafayette, Louisiana-based company is also engaged in sales of branded generic pharmaceutical drugs, while it has its fair share in commercial real estate investment as well.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!